The Westminster lensArchive · §02 Speeches · 178 contributions

Speeches by Cooper.

Every Hansard contribution by Beccy Cooper this parliament, most recent first. Back to the MP page for the headline figures and analysed positions.

Showing 81100 of 178 contributions · most-recent first

← PreviousPage 5 of 9Next →
DateDebate & contributionWords
28 Oct 2025Obesity and Fatty Liver Disease

I thank my hon. Friend for that excellent point and agree absolutely. In our society, we focus on how people look for many reasons, cultural and commercial, but this is purely about health. This is about keeping people healthy on the inside and allowing them to live good quality lives. My hon. Friend is absolutely righ

healtheconomy-jobssocial-care
862
28 Oct 2025Obesity and Fatty Liver Disease

I thank my hon. Friend for that excellent intervention. She is absolutely right. With her public health expertise, she highlights the very real problems that lead to fatty liver disease: our broken food system, the issue with access to good, nutritious food for children in school, and the need to ensure that our stark

healtheconomy-jobssocial-care
350
28 Oct 2025Obesity and Fatty Liver Disease

Thank you, Mr Efford, for chairing the debate this morning. I thank the Minister for her excellent remarks, and all the parliamentary colleagues who have taken the time to be here. I thank the British Liver Trust and everybody who came to hear the debate. I hope they found it edifying and useful. I have no particular f

healtheconomy-jobssocial-care
418
28 Oct 2025Obesity and Fatty Liver Disease

I thank the hon. Member for making that excellent point. He is absolutely right. The issues of the NHS waiting lists are pertinent and stark. Reducing them will mean that we have to get the left shift right as well as invest in acute services. Our policies have failed the population for decades. This debate is an oppor

healtheconomy-jobssocial-care
237
15 Sept 2025Prison Rehabilitation

Rehabilitation is a vital part of prison health programmes, but when prisoners develop infectious diseases such as tuberculosis, they can be isolated from organised programmes such as rehab. Given the risk that interrupted TB treatment can fuel antimicrobial resistance, what steps is the Department taking to ensure tha

crimesocial-care
59
1 Sept 2025 English Devolution and Community Empowerment Bill

This devolution debate today is a continuation of the conversation that has been doing the rounds in Sussex since the announcement that we will be in the first wave of new regions to begin the devolution process. The Bill will allow us to unlock resources at a regional level and to use them to best serve the needs of o

local-governmenteconomy-jobshousing
485
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Going back to health system strengthening, it is the perennial conversation of everybody in international health. Health system strengthening basically is the pandemic preparedness baseline, it is non-communicable diseases baseline; it is everything. For us in the Global North, I wonder what the conversations are aroun

116
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Looking at global health and security as well as specifically at AMR through the global health and security APPG and the AMR APPG, we have been discussing with the Cabinet Office the National Security Strategy and where AMR fits into that particular approach. Baroness Chapman, from an FCDO point of view, how do you see

74
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Will that continue to happen?

5
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Data has been amassed and surveillance systems have been strengthened through the Fleming Fund. Will the funding for that data amalgamation, collection, surveillance-strengthening and fortification continue elsewhere or will that funding not continue and we will simply take what we have learnt and change into a differe

48
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Thank you, Chair. It is good to hear that AMR—antimicrobial resistance—is at the top of your agenda; or I suppose not good, but it is a necessity. Can we please hear about the closure of the Fleming Fund? I know that you know that it has been central for global efforts to build lab capacity, enable data sharing and str

130
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

To be fair, vaccines are also part of the preventative package, so my question is—I absolutely hear you about diagnostics: I chair the APPG on AMR—where in that strategic package of prevention, and perhaps this is a WHO question, are we considering diagnostics? Are we considering diagnostics as part of a preventative m

78
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

—have qualified—

2
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Sorry, Minister, when you said “committed to doing” you are committed to making sure that the Global South—

18
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Going back to health system strengthening, it is the perennial conversation of everybody in international health. Health system strengthening basically is the pandemic preparedness baseline, it is non-communicable diseases baseline; it is everything. For us in the Global North, I wonder what the conversations are aroun

116
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Looking at global health and security as well as specifically at AMR through the global health and security APPG and the AMR APPG, we have been discussing with the Cabinet Office the National Security Strategy and where AMR fits into that particular approach. Baroness Chapman, from an FCDO point of view, how do you see

74
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Will that continue to happen?

5
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Data has been amassed and surveillance systems have been strengthened through the Fleming Fund. Will the funding for that data amalgamation, collection, surveillance-strengthening and fortification continue elsewhere or will that funding not continue and we will simply take what we have learnt and change into a differe

48
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

Thank you, Chair. It is good to hear that AMR—antimicrobial resistance—is at the top of your agenda; or I suppose not good, but it is a necessity. Can we please hear about the closure of the Fleming Fund? I know that you know that it has been central for global efforts to build lab capacity, enable data sharing and str

130
15 Jul 2025International Development Committee — Oral Evidence (HC 1185)

To be fair, vaccines are also part of the preventative package, so my question is—I absolutely hear you about diagnostics: I chair the APPG on AMR—where in that strategic package of prevention, and perhaps this is a WHO question, are we considering diagnostics? Are we considering diagnostics as part of a preventative m

78
← PreviousPage 5 of 9 · click a debate to open the transcript with this MP’s speeches highlightedNext →
Sources
SourceHansard · official report
MethodEach row is one contribution (intervention or speech). Word count from the official text.